Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY 4.0Frontiers in Nephrology

Case Report: Uromodulin-associated autosomal dominant tubulointerstitial kidney disease: case analysis and literature review

  1. 1Department of Nephrology (Second Ward), Hebei Provincial Hospital of Chinese Medicine, Shijiazhuang, China
  2. 2Hebei Key Laboratory of Turbidity Toxin Syndrome, Shijiazhuang, China
  3. 3Hebei Technology Innovation Center of Traditional Chinese Medicine (TCM) Spleen and Kidney Diseases, Shijiazhuang, China

Abstract

Autosomal dominant tubulointerstitial kidney disease caused by UMOD variants (ADTKD-UMOD) is a rare hereditary disorder characterized by early-onset hyperuricemia, gout, and progressive kidney dysfunction. Diagnosis is established by genetic testing. We report the case of a 25-year-old man who presented with elevated serum creatinine (Scr) and uric acid (UA) levels. His father and elder sister had chronic kidney disease of unknown etiology, suggesting an autosomal dominant inheritance pattern. A comprehensive evaluation excluded secondary causes of hyperuricemia and kidney dysfunction. Genetic testing identified a novel heterozygous missense variant, UMOD (NM_003361.4): c.274T>A (p.Cys92Ser), in exon 3 of the gene. The same variant was also detected in affected relatives. In silico analyses predicted a deleterious effect, and the variant was classified as likely pathogenic according to the ACMG/AMP criteria (PM5_Moderate, PP3_Moderate, PM2_Supporting). During longitudinal follow-up with febuxostat treatment, serum urate levels decreased, while progressive deterioration of renal function was observed during the observational period. By analogy to well-characterized pathogenic cysteine-altering UMOD variants, we hypothesize that p.Cys92Ser may promote uromodulin misfolding and endoplasmic reticulum retention and thereby contribute to kidney injury; this mechanistic inference remains to be verified by direct functional experiments for this novel variant. This report expands the mutational spectrum of ADTKD-UMOD and underscores the importance of early genetic testing in at-risk families, as well as standardized long-term follow-up and management for this progressive disorder.

Related

  1. Customized MUC1 Sequencing Enables Diagnosis of Autosomal Dominant Tubulointerstitial Kidney Disease and Unexplained CKD
    José María García-Aznar, María Lara Besada-Cerecedo, Nerea López Aguirre +19
    Kidney international reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. The population frequency of predicted pathogenic variants in the genes associated with Autosomal Dominant Polycystic Liver Disease (ADPLD) and kidney cysts
    Santosh Varughese, Mary Huang, Judy Savige
    PLOS OnePeer-reviewedCC BY 4.0Full textBioinformatics & computational biologyCell biologyPLOS
  3. Extensive Parenchymal Brain Calcification in a Patient With Autosomal Dominant Polycystic Kidney Disease and Stage 5 Chronic Kidney Disease
    Noorelle Khan, Nicholas Streicher
    Clinical case reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. A Case of Autosomal Dominant Alport Syndrome with Normal Type IV Collagen α5 Staining Diagnosed by a Genetic Analysis
    Fuya Tanno, Yoichi Iwafuchi, Naofumi Imai +3
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  5. Tubulointerstitial Nephritis With Uveitis Syndrome: A Case Report and Review of Literature
    Abdulelah Alshaiban
    Clinical case reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCEurope PMCPMC
BibTeX
@article{zheng2026case,
  title = {{Case Report: Uromodulin-associated autosomal dominant tubulointerstitial kidney disease: case analysis and literature review}},
  author = {Linlin Zheng and Hui Gao and Xiangkai Zheng and Xing Zhang and Xiaona Wei},
  journal = {Frontiers in Nephrology},
  year = {2026},
  month = oct,
  doi = {10.3389/fneph.2026.1931661},
  url = {https://doi.org/10.3389/fneph.2026.1931661},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Case Report: Uromodulin-associated autosomal dominant tubulointerstitial kidney disease: case analysis and literature review
AU  - Linlin Zheng
AU  - Hui Gao
AU  - Xiangkai Zheng
AU  - Xing Zhang
AU  - Xiaona Wei
PY  - 2026
DA  - 2026/10/29
JO  - Frontiers in Nephrology
DO  - 10.3389/fneph.2026.1931661
UR  - https://doi.org/10.3389/fneph.2026.1931661
AB  - Autosomal dominant tubulointerstitial kidney disease caused by UMOD variants (ADTKD-UMOD) is a rare hereditary disorder characterized by early-onset hyperuricemia, gout, and progressive kidney dysfunction. Diagnosis is established by genetic testing. We report the case of a 25-year-old man who presented with elevated serum creatinine (Scr) and uric acid (UA) levels. His father and elder sister had chronic kidney disease of unknown etiology, suggesting an autosomal dominant inheritance pattern. A comprehensive evaluation excluded secondary causes of hyperuricemia and kidney dysfunction. Genetic testing identified a novel heterozygous missense variant, UMOD (NM_003361.4): c.274T>A (p.Cys92Ser), in exon 3 of the gene. The same variant was also detected in affected relatives. In silico analyses predicted a deleterious effect, and the variant was classified as likely pathogenic according to the ACMG/AMP criteria (PM5_Moderate, PP3_Moderate, PM2_Supporting). During longitudinal follow-up with febuxostat treatment, serum urate levels decreased, while progressive deterioration of renal function was observed during the observational period. By analogy to well-characterized pathogenic cysteine-altering UMOD variants, we hypothesize that p.Cys92Ser may promote uromodulin misfolding and endoplasmic reticulum retention and thereby contribute to kidney injury; this mechanistic inference remains to be verified by direct functional experiments for this novel variant. This report expands the mutational spectrum of ADTKD-UMOD and underscores the importance of early genetic testing in at-risk families, as well as standardized long-term follow-up and management for this progressive disorder.
SN  - 2813-0626
ER  -